Welcome to our dedicated page for Addus HomeCare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Addus HomeCare Corp EVP and CFO Brian Poff reported open-market sales of 2,861 shares of common stock. The transactions occurred on two days, involving 2,041 shares on one day and 820 shares on the next, at prices a little above $105 per share. According to the footnotes, these sales were executed under a previously established Rule 10b5-1 trading plan and were made to cover tax obligations arising from the vesting of restricted stock awards. After these sales, Poff continues to hold 63,692 shares of Addus HomeCare common stock directly.
Addus HomeCare Corp Chairman and CEO Dirk Allison reported selling a total of 7,352 shares of common stock in open-market transactions. He sold 4,988 shares at an average price of $106.98 on February 24 and 2,364 shares at $105.36 on February 25. These sales were made under a previously established Rule 10b5-1 trading plan to cover tax obligations from vesting restricted stock awards. After the transactions, he directly owns 183,150 shares of Addus HomeCare common stock.
Addus HomeCare Corporation reports strong expansion as a multi-segment home care provider focused on personal care, hospice and home health services. For the year ended December 31, 2025, total net service revenue rose to $1,422,530,000 from $1,154,599,000, while net income increased to $95,910,000 from $73,598,000.
The company served about 107,000 consumers across 23 states through roughly 262 offices, with a model centered on mostly dual-eligible Medicare/Medicaid patients and growing relationships with managed care organizations. Growth comes from both organic initiatives and acquisitions; six deals completed in 2024–2025 added meaningful revenue. Addus highlights opportunities from aging demographics, home- and community-based services demand and industry consolidation, while also warning about significant regulatory, Medicaid funding, labor cost and macroeconomic risks that could pressure margins and growth.
Addus HomeCare Corp executive Monica Raines reported both a stock award and a small sale of shares. On February 20, 2026, she acquired 2,858 shares of common stock as a grant at $0.00 per share, vesting in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change-in-control provisions.
On February 23, 2026, she sold 446 shares of common stock in an open-market transaction at an average price of $114.91 per share under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from restricted stock vesting. After these transactions, she directly held 14,457 shares of Addus common stock.
Addus HomeCare Corp EVP and Chief HR Officer Roberton James Stevenson reported a stock grant and a related share sale. On February 20, he acquired 2,858 shares of common stock as a grant, at no cost, which vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and potential acceleration upon a change in control. On February 23, he sold 561 shares at $114.91 per share under a pre-set Rule 10b5-1 plan to cover tax obligations from vesting restricted stock awards, leaving 14,881 shares directly owned.
Addus HomeCare Corp EVP and Chief Development Officer Cliff Donald Blessing reported mixed share activity. He sold 371 shares of common stock in an open-market transaction at $114.91 per share under a pre-set 10b5-1 plan to cover tax obligations. He also received a grant of 2,858 restricted shares that vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Following these transactions, he directly holds 12,888 shares.
Addus HomeCare Corp executive Michael D. Wattenbarger reported both an equity grant and a small share sale. On February 20, 2026, he acquired 3,117 shares of common stock as a grant with no purchase price, lifting his holdings to 10,913 shares.
The granted shares vest in three equal installments on each of February 20, 2027, 2028, and 2029, subject to continued service and change-in-control provisions. On February 23, 2026, he sold 577 shares at $114.91 per share in an open-market trade under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 10,336 directly owned shares.
Addus HomeCare Corp executive David W. Tucker reported both an equity award and a small share sale. On February 20, 2026, he acquired 3,429 shares of common stock as a grant or award at no cost. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and customary change-in-control provisions.
On February 23, 2026, Tucker executed an open-market sale of 658 shares of common stock at $114.91 per share. According to the footnote, this sale was made under a previously established Rule 10b5-1 trading plan adopted on March 13, 2025 and was intended to satisfy tax obligations arising from the vesting of restricted stock awards.
Addus HomeCare Corp executive Darby Anderson reported mixed share activity. On February 20, 2026, he acquired 3,897 shares of common stock as a grant that will vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change‑in‑control provisions.
On February 23, 2026, he sold 666 shares of common stock at $114.91 per share in an open‑market transaction under a previously established Rule 10b5‑1 trading plan adopted on March 5, 2025, to cover tax obligations from vesting restricted stock awards. After these transactions, he held 47,375 shares directly.
Addus HomeCare Corp EVP and Chief Legal Officer Sean Gaffney reported two stock transactions. He received a grant of 3,897 common shares at no cost, vesting in three equal installments on February 20 of 2027, 2028, and 2029. He then executed an open-market sale of 737 shares at $114.91 under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 21,339 directly held shares.